期刊文献+

TAC1与外排泵基因对白念珠菌生物膜形成的影响 被引量:3

The Influence of TAC1 and Efflux Pump Genes on Candida Albicans Biofilm Formation
下载PDF
导出
摘要 目的探究白念珠菌生物膜形成过程中不同时期的锌簇转录因子TAC1与外排泵基因MDR1,CDR1,CDR2与白念珠菌生物膜耐药的关系。方法 96孔板培养白念珠菌生物膜,MTT法分别测定白念珠菌生物膜形成不同时期(4h,24h,48h)对氟康唑的敏感性。6孔板培养白念珠菌生物膜,分别在4h,24h,48h提取生物膜的总RNA,逆转录cDNA,RT-PCR检测TAC1,MDR1,CDR1,CDR2的基因表达量。结果白念珠菌在生物膜的形成过程中TAC1,MDR1,CDR1,CDR2的基因表达差异具统计学意义,经过Bonferroni多重比较,结果显示标准株00889 TAC1,MDR1,CDR1,CDR2早期基因表达量比中、晚期高。临床敏感株359 TAC1,MDR1,CDR1,CDR2中期基因表达量比晚期高。结论锌簇转录因子TAC1和外排泵基因可能在白念珠菌生物膜的早中期对氟康唑的耐药形成中发挥了一定作用。 Objective To explore the role of resistance-related genes encoding TAC1 MDR1 CDR1 CDR2 in the process of biofilm formation of Candida albicans. Methods Biofilms were formed and the susceptibility to fluconazole in different biofilm periods of C. albicans was respectively determined by MTr method. The total RNA was extracted from biofilms in different phase and then cDNA was synthesized. The expression of bio- film-related genes was detected by quantitative real-time PCR. Results The expression of TAC1, MDR1, CDR1 and CDR2 had meaningful differences in the process of candidal biofilm formation. Bonferroni test(P 〈 0. 05) revealed that the expression of TAC1, MDR1, CDR1 and CDR2 in the earlier phase was higher than that in the middle and late phases for the isolate 00889. For the clinical isolate 359 ,the expression of TAC1 MDR1, CDR1 and CDR2 in the middle phease was higer than that in the late phase. Conclusion It is likely that the TAC1 and efflux pump genes may play a role in the resistance to fluconazole of candidal biofilms in the early and middle phease.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2014年第5期467-471,共5页 The Chinese Journal of Dermatovenereology
关键词 白念珠菌 生物膜 RT-PCR 表达 TAC1 耐药 Candida albicans Biofilms RT-PCR Expression TAC1 Resistance
  • 相关文献

参考文献15

  • 1Cateau E, Berjeaud JM, Rodier MH,et al. Fungal biofilm inhibition by a component naturally produced by Candida albicans yeasts growing as a biofilm [ J ]. Int J Antimicrob Agents, 2008 ,31 (2) : 166 - 170.
  • 2Finkel JS, Mitchell AP. Genetic control of Candida albicans biofilm de- velopment [ J ]. Nat Rev Microbiol, 2011,9 (2) : 109 - 118.
  • 3Ramage G, Vandewalle K, Wickes BL, et al. Characteristics of biofilm formation by Candida albicans [ J ]. Rev Iberoam Micol,2001,18 (4) : 163 - 170.
  • 4Hasan F, Xess I, Wang X, et al. Biofilm formation in clinical Candida isolates and its association with virulence [ J ]. Microbes Infect, 2009, 11(8 -9) : 753 -761.
  • 5Pierce CG, Uppuluri P, Tummala S, et al. A 96 well microtiter plate- based method for monitoring formation and antifungal susceptibility tes- ting of Candida albicans biofilms[J]. J Vis Exp, 2010, (44) : 2287.
  • 6Chandra J, Mukherjee PK, Leidich SD. Antifungal resistance of can- didal biofilrns formed on denture acrylic in vitro[ J]. J Dent Res ,2001 , 80(3 ) :903 -908.
  • 7满旭,刘原君,李春莉,郭雅莉,亓玉青,刘全忠,王惠平.白念珠菌锌簇转录因子编码基因表达与氟康唑耐药的关系[J].中国皮肤性病学杂志,2013,27(2):131-133. 被引量:4
  • 8Andes D, Nett J, Oschel P, et al. Development and characterization of an in vivo central venous catheter Candida albicans biofilm[ J ]. Model. Infect Immun, 2004 , 72(10): 6023-6031.
  • 9Uppuluri P, Pierce CG, Lopez-Ribot JL. Candida albicans Biofilm For- mation and its Clinical Consequenees[ J]. Future Mierobiol, 2009 , 4 (10) : 1235 -1237.
  • 10Douglas LJ. Penetration of antifugal agents through Candida biofilms [ J]. Methods Mol Biol, 2009,499:37 -44.

二级参考文献9

  • 1White TC,Marr KA,Bowden RA. Clinical,cellular,and molecular factors that contribute to antifungal drug resistance[J].Clinical Microbiology Reviews,1998,(02):382-402.
  • 2Michael AP,Pfaller MA,Shean DJ. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved StandardSecond edition[NCCLS document M27-A2,NCCLS][R].2002.
  • 3MacPherson S,Akache B,Weber S. Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes[J].Antimicrobial Agents and Chemotherapy,2005,(05):1745-1752.doi:10.1128/AAC.49.5.1745-1752.2005.
  • 4Hoot SJ,Oliver B J,White TC. Candida albicans UPC2 is transcriptionally induced in response to antifungal drugs and anaerobicity through Upc2p-dependent and-independent mechanisms[J].Microbiology,2008,(09):2748-2756.doi:10.1099/mic.0.2008/017475-0.
  • 5Dunkel N,Liu TT,Barker KS. A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate[J].Eukaryotic Cell,2008,(07):1180-1190.doi:10.1128/EC.00103-08.
  • 6Sadri Z,Sandra W,Perrine B. Genomewide Location Analysis of Candida albicans Upc2p,a Regulator of Sterol Metabolism and Azole Drug Resistance[J].Eukaryotic Cell,2008,(05):836-847.
  • 7Perea S,López-Ribot JL,Kirkpatrick WR. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans.strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients[J].Antimicrobial Agents and Chemotherapy,2001,(10):2676-2684.
  • 8Karababa M,Coste AT,Sanglard D. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters[J].Antimicrobial Agents and Chemotherapy,2004,(04):3064-3079.
  • 9景伟芳,李春莉,王惠平.白念珠菌506株对氟康唑和伊曲康唑的体外药敏试验[J].中国皮肤性病学杂志,2011,25(1):30-32. 被引量:5

共引文献3

同被引文献10

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部